Exelixis
EXEL
#1709
Rank
$10.14 B
Marketcap
$35.54
Share price
-0.14%
Change (1 day)
58.45%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Number of shares outstanding for Exelixis (EXEL)

Number of shares outstanding as of December 2024 : 285,622,000

According to Exelixis's latest financial reports and stock price the company's current number of shares outstanding is 285,622,000. At the end of 2024 the company had 285,622,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Exelixis from 2000 to 2024

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20240.28 B-7.41%
20230.30 B-4.57%
20220.32 B1.79%
20210.31 B2.19%
20200.31 B2.11%
20190.30 B1.65%
20180.29 B1.14%
20170.29 B2.73%
20160.28 B26.69%
20150.22 B16.32%
20140.19 B6.05%
20130.18 B10.83%
20120.16 B28.81%
20110.12 B18.84%
20100.10 B1.24%
20090.10 B1.69%
20080.10 B7.1%
200798.55 M17.07%
200684.17 M5.83%
200579.54 M10.21%
200472.17 M1.66%
200370.99 M25.69%
200256.48 M18.29%
200147.75 M15.96%
200041.17 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
2,040,000,000 614.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
2,506,000,000 777.38%๐Ÿ‡ซ๐Ÿ‡ท France
2,532,030,145 786.50%๐Ÿ‡บ๐Ÿ‡ธ USA
2,028,000,000 610.03%๐Ÿ‡บ๐Ÿ‡ธ USA
537,000,000 88.01%๐Ÿ‡บ๐Ÿ‡ธ USA
2,407,298,000 742.83%๐Ÿ‡บ๐Ÿ‡ธ USA
5,667,000,000 1,884.09%๐Ÿ‡บ๐Ÿ‡ธ USA
5,940,924-97.92%๐Ÿ‡บ๐Ÿ‡ธ USA
34,618,000-87.88%๐Ÿ‡บ๐Ÿ‡ธ USA